Table 2: Baseline demographics for IVA and LUM/IVA CFTR
modulator studies.
Ivacaftor Baseline
Demographics n=20 |
Combination Baseline
Demographics n=32 |
|
Age – mean years |
32.5 (18-65) |
33.05 (20-53) |
Male – n (%) |
12 (60%) |
20 (62.5%) |
Height – mean cm |
169 (150-182) |
169.3(151-187) |
Weight - kg mean |
67.25 (49.05-121.7) |
60.7 (38.95-85.5) |
BMI |
25.8 (18-36.4) |
21.02(16.9-28.37) |
Sweat Chloride mmol/L |
98.05 (56-113) |
Not done |
Smoker – n |
0 |
0 |
Oxygen Supplementation |
Nil |
Nil |
Exocrine Pancreatic
Insufficiency – n |
18 |
32 |
CF Diabetes Mellitus – n |
1 |
15 |
CF Liver Disease – n |
1 |
12 |
Fat Mass % |
23.03 (4-42) |
21.07 (2.4-41.1) |
Genotype |
||
G551D/G551D |
2 |
N/A |
G551D/ df508 |
12 |
N/A |
G551D/Other |
G524X (2), V520F (1), Unknown
(2) |
N/A |
df508/df508 |
N/A |
32 |
Lung Function |
||
FEV1 % predicted mean |
54.5 (20-99) |
41.9 (24-95) |
FVC % predicted mean |
71.05 (40-96) |
64.1 (38-107) |
Baseline Cognition values |
||
MOCA score |
27.6 (22-30) |
27.5 (25-30) |
Trail A – speed seconds |
28.06 (23-36.9) |
25.4 (12.3-38) |
Trail B – speed seconds |
Not done |
50.4 (20-83.60) |
Cogstate™ score |
Not done |
9.02X10-17(-.95-0.80) |